Principal Financial Group’s Cytek Biosciences CTKB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.95M | Buy |
572,387
+51,644
| +10% | +$176K | ﹤0.01% | 1806 |
|
|
2025
Q1 | $2.09M | Buy |
520,743
+13,818
| +3% | +$55.4K | ﹤0.01% | 1761 |
|
|
2024
Q4 | $3.29M | Buy |
506,925
+3,753
| +0.7% | +$24.4K | ﹤0.01% | 1703 |
|
|
2024
Q3 | $2.79M | Buy |
503,172
+23,028
| +5% | +$128K | ﹤0.01% | 1720 |
|
|
2024
Q2 | $2.68M | Sell |
480,144
-38,550
| -7% | -$215K | ﹤0.01% | 1715 |
|
|
2024
Q1 | $3.48M | Sell |
518,694
-31,729
| -6% | -$213K | ﹤0.01% | 1684 |
|
|
2023
Q4 | $5.02M | Sell |
550,423
-8,123
| -1% | -$74.1K | ﹤0.01% | 1554 |
|
|
2023
Q3 | $3.08M | Buy |
558,546
+82,456
| +17% | +$455K | ﹤0.01% | 1675 |
|
|
2023
Q2 | $4.07M | Buy |
476,090
+433,065
| +1,007% | +$3.7M | ﹤0.01% | 1612 |
|
|
2023
Q1 | $395K | Sell |
43,025
-4,621
| -10% | -$42.5K | ﹤0.01% | 2026 |
|
|
2022
Q4 | $486K | Buy |
47,646
+1,634
| +4% | +$16.7K | ﹤0.01% | 1983 |
|
|
2022
Q3 | $678K | Sell |
46,012
-52,388
| -53% | -$772K | ﹤0.01% | 1902 |
|
|
2022
Q2 | $1.06M | Buy |
98,400
+82,510
| +519% | +$885K | ﹤0.01% | 1909 |
|
|
2022
Q1 | $171K | Buy |
+15,890
| New | +$171K | ﹤0.01% | 2364 |
|